Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Using gene targeting techniques, mice that have been generated with two germ-line p53 null alleles (homozygotes) develop normally but are highly susceptible to early onset spontaneous tumours. Here, we show that mice with a single null p53 allele (heterozygotes) produced in the same way are also susceptible to spontaneous tumours, but with a delayed onset compared to homozygotes. The most frequent tumour type in homozygotes was malignant lymphoma; in heterozygotes, osteosarcomas and soft tissue sarcomas predominated. Heterozygous mice treated with a liver carcinogen, dimethylnitrosamine, showed a decreased survival time in comparison to treated wild type mice, suggesting that the p53-deficient mice may be useful for some in vivo carcinogenesis assays.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure of MEFs to oxidative stress activates the p19/ARF-p53 pathway, which leads to cellular senescence (Harvey et al., 1993; Kamijo et al., 1997).”
From Single-Cell Transcriptome Analysis Reveals Six Subpopulations Reflecting Distinct Cellular Fates in Senescent Mouse Embryonic Fibroblasts (2020) · cites this paper as Harvey et al., 1993
In the citing paper
“Importantly, in both the squamous cell carcinoma model and the breast adenocarcinoma model, the emergent cancers show activation of endogenous telomerase activity.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [99]
In the citing paper
“More recently, lentiviral oncogene transduction of human mammary epithelia cells directly from reduction mammoplasty results in breast adenocarcinoma following short-term culture and immediate orthotopic implantation (99).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [99]
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationThe p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Moll, U. M., Riou, G., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7262 · Cited by 575
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Kemp, C. J., Donehower, L. A., Bradley, A., & Balmain, A. (1993) · Cell · doi:10.1016/0092-8674(93)90461-x · Cited by 457
Self-citationLavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen, A.-L., Li, F. P., Garber, J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262002 · Cited by 379
Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beaughamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262001 · Cited by 307
Friend virus-induced erythroleukemia and the multistage nature of cancer
Ben-David, Y., & Bernsteint, A. (1991) · Cell · doi:10.1016/0092-8674(91)90428-2 · Cited by 237
Genetics of cancer predisposition.
Hansen, M. F., & Cavenee, W. K. (1987) · PubMed · Cited by 193
Infrequent p53 gene mutations in medulloblastomas.
Saylors, R. L., Sidransky, D., Friedman, H. S., Bigner, S. H., Bigner, D. D., Vogelstein, B., & Brodeur, G. M. (1991) · PubMed · Cited by 186
International incidence of childhood cancer
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90128-5 · Cited by 157
Burns, P. A., Kemp, C. J., Jv, G., Lane, D. P., Bremner, R., & Balmain, A. (1991) · PubMed · Cited by 139
Apoptosis—the mechanism of cell death in dimethylnitrosamine‐induced hepatotoxicity
Pritchard, D. J., & Butler, W. H. (1989) · The Journal of Pathology · doi:10.1002/path.1711580314 · Cited by 102
The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang, F., Syrjänen, S., Kurvinen, K., & Syrjänen, K. J. (1993) · PubMed · Cited by 101
Rare occurrence of P53 gene mutations in multiple myeloma
Preudhomme, C., Facon, T. T. F., Zandecki, M., Vanrumbeke, M., Laı̈, J. L., Nataf, E., Loucheux‐Lefebvre, M. H., Kerckaert, J. P., & Fenaux, P. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08253.x · Cited by 73
U.S. childhood cancer deaths by cell type, 1960-68
Miller, R. W., & Dalager, N. A. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80511-1 · Cited by 42
Pulmonary and Hepatic Oncogenesis During Treatment of Male RF Mice With Dimethylnitrosamine 2
Clapp, N. K., Craig, A. W., & Toya, R. E. (1968) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/41.5.1213 · Cited by 34
Tsushita, K., Hotia, T., Ichikawa, A., & Saito, H. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08263.x · Cited by 15
[Biotransformation of dimethylnitrosamine].
Fournier, P. (1990) · PubMed · Cited by 14
Research works printed but not linked: 1
- Triche, T.J. Unique features of childhood cancer. In Cancer Medicine, 3rd edn, (eds Holland, J.F. et al.) 2144–2152 (Lea & Febiger, Malvern, Philadelphia, 1993).
Cited by
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Metadata
- Authors
- Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature Genetics
- Published
- 1993-11
- Volume
- 5
- Issue
- 3
- Pages
- 225-229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2023068350
- Cited by
- 542
- References
- 34
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 8 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 10 · 2014: 12 · 2013: 11 · 2012: 23
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA54897, R01CA054897)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, p53-deficient mice, spontaneous tumor development, lymphoma, osteosarcoma, soft tissue sarcoma, N-nitrosodimethylamine, hepatocarcinogenesis, cancer susceptibility
- MeSH terms
- Animals, Dimethylnitrosamine, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Neoplasms, Experimental, Genes, p53, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.